sb 203580 has been researched along with sk&f-38393 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sk&f-38393) | Trials (sk&f-38393) | Recent Studies (post-2010) (sk&f-38393) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 2,012 | 29 | 242 |
| Protein | Taxonomy | sb 203580 (IC50) | sk&f-38393 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.8 | |
| D | Rattus norvegicus (Norway rat) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, B; Li, GY; Li, T; Ma, TH; Zheng, YC | 1 |
1 other study(ies) available for sb 203580 and sk&f-38393
| Article | Year |
|---|---|
The D₁ dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Butadienes; Cell Line; Dopamine Agonists; Dopamine Antagonists; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hydrogen Peroxide; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Nitriles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Receptors, Dopamine D1; Retinal Ganglion Cells; Signal Transduction | 2012 |